formoterol/budesonide (CXG87) / Chance Pharma - LARVOL DELTA

Chance Pharmaceuticals…announced that the Center for Drug Evaluation of China's National Medical Products Administration (NMPA) has accepted the new drug application (NDA) for CXG87 (Budesonide and Formoterol Fumarate Powder for Inhalation (IV), hard capsule) (PRNewswire) - "The company has completed a multicenter, randomized, blinded, positive-controlled Phase III clinical trial (www.chinadrugtrials.org.cn identifier: CTR20250298). The study was designed to evaluate the clinical efficacy and safety of CXG87 in adult patients with bronchial asthma and has achieved positive results."

China filing • Asthma